Aim is to add three clinical programs in solid cancer starting H1 2019
BioInvent Capital Markets Day in Stockholm on December 10 to provide information on existing programs and rationale for new programs
Company to engage in intensive investor meeting program in the U.S., Europe and Israel in October-November
PR Newswire
LUND, Sweden, Oct. 16, 2018